Literature DB >> 1508841

Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.

T Yasumasu1, T Ueda, J Uozumi, Y Mihara, J Kumazawa.   

Abstract

To clarify the difference in nephrotoxicity between cisplatin and carboplatin, the pharmacokinetics of platinum, renal function and nuclear DNA synthesis in renal cortical and outer medullary cells were studied in rats which had received cisplatin or carboplatin. Male Sprague-Dawley rats were given either cisplatin or carboplatin intravenously at an equi-toxic dose (LD10 or LD50) and were killed at various times within 7 days after the injection. Cisplatin bound to plasma proteins more avidly than carboplatin. Much more platinum was detectable in the renal nuclei after cisplatin injection than after carboplatin injection. BUN and serum creatinine levels in the rats treated with 8.5 mg/kg of cisplatin were significantly higher than in those treated with 100 mg/kg of carboplatin. Cisplatin markedly suppressed the renal nuclear DNA synthesis both in vivo and in vitro, when compared with carboplatin. It is concluded that the differences in nephrotoxicity between cisplatin and carboplatin are related to their different inhibitory effects on nuclear DNA synthesis in the renal cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508841     DOI: 10.1111/j.1600-0773.1992.tb00445.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  10 in total

Review 1.  Recent and current clinical trials in canine appendicular osteosarcoma.

Authors:  Andrew C Poon; Arata Matsuyama; Anthony J Mutsaers
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

2.  A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.

Authors:  J T Hartmann; L M Fels; S Knop; H Stolt; L Kanz; C Bokemeyer
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

3.  Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties.

Authors:  Ramindhu Galgamuwa; Kristine Hardy; Jane E Dahlstrom; Anneke C Blackburn; Elize Wium; Melissa Rooke; Jean Y Cappello; Padmaja Tummala; Hardip R Patel; Aaron Chuah; Luyang Tian; Linda McMorrow; Philip G Board; Angelo Theodoratos
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

4.  Improved outcome of central nervous system germ cell tumors: implications for the role of risk-adapted intensive chemotherapy.

Authors:  Keon Hee Yoo; Soo Hyun Lee; Jeehun Lee; Ki Woong Sung; Hye Lim Jung; Hong Hoe Koo; Do Hoon Lim; Jong Hyun Kim; Hyung Jin Shin
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

5.  Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients.

Authors:  Mustafa E Ibrahim; Cara Chang; Yichun Hu; Susan L Hogan; Nickie Mercke; Madeleine Gomez; Cindy L O'Bryant; Daniel W Bowles; Blessy George; Xia Wen; Brian Buckley; Lauren Aleksunes; Melanie S Joy
Journal:  Eur J Clin Pharmacol       Date:  2018-09-15       Impact factor: 2.953

Review 6.  Major combined electrolyte deficiency during therapy with low-dose cisplatin, 5-fluorouracil and interferon alpha: report on several cases and review of the literature [ISRCTN62866759].

Authors:  Katrin Hoffmann; Angela Marten; Katja Lindel; Stefan Fritz; Dirk Jager; Markus W Buchler; Jan Schmidt
Journal:  BMC Cancer       Date:  2006-05-10       Impact factor: 4.430

Review 7.  Role of transporters in the distribution of platinum-based drugs.

Authors:  Saliha Harrach; Giuliano Ciarimboli
Journal:  Front Pharmacol       Date:  2015-04-24       Impact factor: 5.810

8.  Pharmacokinetics and tissue distribution of novel platinum containing anticancer agent BP-C1 studied in rabbits using sector field inductively coupled plasma mass spectrometry.

Authors:  Denis V Navolotskii; Natalya B Ivanenko; Nikolay D Solovyev; Elena I Fedoros; Andrey V Panchenko
Journal:  Drug Test Anal       Date:  2015-06-10       Impact factor: 3.345

9.  Effects of the potassium-sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells.

Authors:  Andrew C Poon; Jordon M Inkol; Anita K Luu; Anthony J Mutsaers
Journal:  J Vet Intern Med       Date:  2018-12-17       Impact factor: 3.333

Review 10.  Membrane transporters as mediators of Cisplatin effects and side effects.

Authors:  Giuliano Ciarimboli
Journal:  Scientifica (Cairo)       Date:  2012-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.